Early results of bladder-cancer screening in a high-risk population of heavy smokers

BJU International

Volumn 102, Issue 3, 2008, Pages 291-296

  Steiner, Hannes ^a   Bergmeister, Maria ^a   Verdorfer, Irmgard ^a   Granig, Thomas ^a   Mikuz, Gregor ^a   Bartsch, Georg ^a   Stoehr, Brigitte ^a   Brunner, Andrea ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Bladder cancer; Cytology; NMP22; Screening; Urine dipstick; UroVysion

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER DIAGNOSIS; CANCER SCREENING; CARCINOMA IN SITU; CONTROLLED STUDY; CYSTOSCOPY; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HISTOLOGY; HUMAN; INVERTED PAPILLOMA; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIODIAGNOSIS; SMOKING; URINALYSIS; UROGENITAL TRACT TUMOR;

ADULT; AGED; AGED, 80 AND OVER; EPIDEMIOLOGIC METHODS; FEMALE; HEMATURIA; HUMANS; MALE; MIDDLE AGED; NUCLEAR PROTEINS; PROGRAM EVALUATION; REAGENT STRIPS; SMOKING; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 47649104644     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2008.07596.x     Document Type: Article

References (21)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007 57 : 43 66
2. Feldman AR, Kessler L, Myers MH, Naughton MD. The prevalence of cancer. Estimates based on the Connecticut Tumor Registry. N Engl J Med 1986 315 : 1394 7
3. Varkarakis MJ, Gaeta J, Moore RH, Murphy GP. Superficial bladder tumor. Aspects of clinical progression. Urology 1974 4 : 414 20
4. Grossman HB, Messing E, Soloway M et al. Detection of bladder cancer using a point-of-care proteomic assay. JAMA 2005 293 : 810 6
5. Walsh PC. Campbell's Urology. Philadelphia : Saunders, 2002
6. Brennan P, Bogillot O, Cordier S et al. Cigarette smoking and bladder cancer in men: a pooled analysis of 11 case-control studies. Int J Cancer 2000 86 : 289 94
7. Brennan P, Bogillot O, Greiser E et al. The contribution of cigarette smoking to bladder cancer in women (pooled European data). Cancer Causes Control 2001 12 : 411 7
8. Messing EM, Madeb R, Young T et al. Long-term outcome of hematuria home screening for bladder cancer in men. Cancer 2006 107 : 2173 9
9. Lotan Y, Svatek RS, Sagalowsky AI. Should we screen for bladder cancer in a high-risk population?: a cost per life-year saved analysis. Cancer 2006 107 : 982 90
10. Oosterlinck W, Lobel B, Jakse G, Malmstrom PU, Stockle M, Sternberg C. Guidelines on bladder cancer. Eur Urol 2002 41 : 105 12
11. Botteman MF, Pashos CL, Redaelli A, Laskin B, Hauser R. The health economics of bladder cancer: a comprehensive review of the published literature. Pharmacoeconomics 2003 21 : 1315 30
12. Goldstein MM, Messing EM. Prostate and bladder cancer screening. J Am Coll Surg 1998 186 : 63 74
13. Messing EM, Young TB, Hunt VB, Wehbie JM, Rust P. Urinary tract cancers found by homescreening with hematuria dipsticks in healthy men over 50 years of age. Cancer 1989 64 : 2361 7
14. Britton JP, Dowell AC, Whelan P. Dipstick haematuria and bladder cancer in men over 60: results of a community study. BMJ 1989 299 : 1010 2
15. Messing EM, Young TB, Hunt VB et al. Comparison of bladder cancer outcome in men undergoing hematuria home screening versus those with standard clinical presentations. Urology 1995 45 : 387 96
16. Madeb R, Messing EM. Long-term outcome of home dipstick testing for hematuria. World J Urol 2008 26 : 19 24
17. Amin MB. Urothelial dysplasia. In Eble JN, Sauter G, Epstein JI, Sesterhenn IA, World Health Organisation Classification of Tumours. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. Lyon : IARC Press, 2004 : 111 2
18. Sauter G. Inverted papilloma. In Eble JN, Sauter G, Epstein JI, Sesterhenn IA, World Health Organisation Classification of Tumours. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. Lyon : IARC Press, 2004 : 114 5
19. Epstein JI, Amin MB, Reuter VR, Mostofi FK. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 1998 22 : 1435 48
20. Ponsky LE, Sharma S, Pandrangi L et al. Screening and monitoring for bladder cancer: refining the use of NMP22. J Urol 2001 166 : 75 8
21. Sarosdy MF, Kahn PR, Ziffer MD et al. Use of a multitarget fluorescence in situ hybridization assay to diagnose bladder cancer in patients with hematuria. J Urol 2006 176 : 44 7